Showing 1 - 2 results of 2 for search 'Cecilia Lezcano', query time: 0.02s
Refine Results
-
1
-
2
Use of dupilumab to manage a grade 3 cutaneous adverse effect from enfortumab vedotin/pembrolizumab treatment in a patient with metastatic urothelial carcinoma by Maura C. Gillis, BA, Vanessa R. Weir, BA, Cecilia Lezcano, MD, Gopa Iyer, MD, Allison Gordon, MD
Published 2025-02-01Get full text
Article